Mohammad Aatif1, Ghazala Muteeb2, Abdulrahman Alsultan3, Adil Alshoaibi4, Bachir Yahia Khelif1. 1. Department of Public Health, College of Applied Medical Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia. 2. Department of Nursing, College of Applied Medical Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia. 3. Department of Biomedical Sciences, College of Applied Medical Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia. 4. Department of Physics, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Abstract
The high risk of morbidity and mortality associated with SARS-CoV-2 has accelerated the development of many potential vaccines. However, these vaccines are designed against SARS-CoV-2 isolated in Wuhan, China, and thereby may not be effective against other SARS-CoV-2 variants such as the United Kingdom variant (VUI-202012/01). The UK SARS-CoV-2 variant possesses D614G mutation in the Spike protein, which impart it a high rate of infection. Therefore, newer strategies are warranted to design novel vaccines and drug candidates specifically designed against the mutated forms of SARS-CoV-2. One such strategy is to target ACE2 (angiotensin-converting enzyme2)-Spike protein RBD (receptor binding domain) interaction. Here, we generated a homology model of Spike protein RBD of SARS-CoV-2 UK strain and screened a marine seaweed database employing different computational approaches. On the basis of high-throughput virtual screening, standard precision, and extra precision molecular docking, we identified BE011 (Dieckol) as the most potent compounds against RBD. However, Dieckol did not display drug-like properties, and thus different derivatives of it were generated in silico and evaluated for binding potential and drug-like properties. One Dieckol derivative (DK07) displayed good binding affinity for RBD along with acceptable physicochemical, pharmacokinetic, drug-likeness, and ADMET properties. Analysis of the RBD-DK07 interaction suggested the formation of hydrogen bonds, electrostatic interactions, and hydrophobic interactions with key residues mediating the ACE2-RBD interaction. Molecular dynamics simulation confirmed the stability of the RBD-DK07 complex. Free energy calculations suggested the primary role of electrostatic and Van der Waals' interaction in stabilizing the RBD-DK07 complex. Thus, DK07 may be developed as a potential inhibitor of the RBD-ACE2 interaction. However, these results warrant further validation by in vitro and in vivo studies.
Tnclass="Chemical">he high risk of morbidity and <class="Chemical">span class="Disease">mortality associated with SARS-CoV-2 has accelerated the development of many potential vaccines. However, these vaccines are designed against SARS-CoV-2 isolated in Wuhan, China, and thereby may not be effective against other SARS-CoV-2 variants such as the United Kingdom variant (VUI-202012/01). The UK SARS-CoV-2 variant possesses D614G mutation in theSpike protein, which impart it a high rate of infection. Therefore, newer strategies are warranted to design novel vaccines and drug candidates specifically designed against the mutated forms of SARS-CoV-2. One such strategy is to target ACE2 (angiotensin-converting enzyme2)-Spike protein RBD (receptor binding domain) interaction. Here, we generated a homology model of Spike protein RBD of SARS-CoV-2 UK strain and screened a marine seaweed database employing different computational approaches. On the basis of high-throughput virtual screening, standard precision, and extra precision molecular docking, we identified BE011 (Dieckol) as the most potent compounds against RBD. However, Dieckol did not display drug-like properties, and thus different derivatives of it were generated in silico and evaluated for binding potential and drug-like properties. One Dieckol derivative (DK07) displayed good binding affinity for RBD along with acceptable physicochemical, pharmacokinetic, drug-likeness, and ADMET properties. Analysis of the RBD-DK07 interaction suggested the formation of hydrogen bonds, electrostatic interactions, and hydrophobic interactions with key residues mediating theACE2-RBD interaction. Molecular dynamics simulation confirmed the stability of the RBD-DK07 complex. Free energy calculations suggested the primary role of electrostatic and Van der Waals' interaction in stabilizing the RBD-DK07 complex. Thus, DK07 may be developed as a potential inhibitor of the RBD-ACE2 interaction. However, these results warrant further validation by in vitro and in vivo studies.
Entities:
Keywords:
COVID-19; marine-derived compounds; molecular docking and simulation; natural compounds; seaweeds; spike protein
Authors: Julia Liang; Eleni Pitsillou; Chris Karagiannis; Kevion K Darmawan; Ken Ng; Andrew Hung; Tom C Karagiannis Journal: Comput Biol Chem Date: 2020-05-28 Impact factor: 2.877
Authors: Ji-Young Park; Jang Hoon Kim; Jung Min Kwon; Hyung-Jun Kwon; Hyung Jae Jeong; Young Min Kim; Doman Kim; Woo Song Lee; Young Bae Ryu Journal: Bioorg Med Chem Date: 2013-04-22 Impact factor: 3.641
Authors: Aljawharah A Alqathama; Rizwan Ahmad; Ruba B Alsaedi; Raghad A Alghamdi; Ekram H Abkar; Rola H Alrehaly; Ashraf N Abdalla Journal: Pharm Biol Date: 2022-12 Impact factor: 3.503
Authors: Nikheel Bhojraj Rathod; Nariman Elabed; Fatih Özogul; Joe M Regenstein; Charis M Galanakis; Sulaiman Omar Aljaloud; Salam A Ibrahim Journal: Front Microbiol Date: 2022-06-22 Impact factor: 6.064